Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study.

Sergio De Filippis Anna Pugliese Michael Cronquist Christensen Gianluca Rosso Marco Di NicolaKenneth SimonsenHongye Ren

Published in: Neuropsychiatric disease and treatment (2022)

Clinically relevant and sustained improvements in overall functioning, symptoms of depression, cognitive symptoms, and health-related quality of life were observed in patients with MDD treated with vortioxetine over a period of 6 months in routine care in Italy, including a high proportion of elderly patients.

Keyphrases

major depressive disorder
clinical practice
bipolar disorder
sleep quality
randomized controlled trial
healthcare
systematic review
depressive symptoms
palliative care
quality improvement
chronic pain